Capital Group Private Client Services, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Capital Group Private Client Services, Inc.
- $10.2 Billion
- Q4 2024
A detailed history of Capital Group Private Client Services, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital Group Private Client Services, Inc. holds 91,330 shares of REGN stock, worth $65.1 Million. This represents 0.64% of its overall portfolio holdings.
Number of Shares
91,330
Previous 110,895
17.64%
Holding current value
$65.1 Million
Previous $117 Million
44.19%
% of portfolio
0.64%
Previous 1.17%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
85.7MCall Options Held
1.53MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.62 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$5.04 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.45 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.38 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.5B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...